PATENT CLAIM ANALYSIS

Application Number: 16357918
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "04400A"]

Abstract:
An antisense molecule capable of binding to a selected target site to induce exon skipping in the dystrophin gene, as set forth in SEQ ID NO: 1 to 59.

Claim (Index 8):
The method of  claim 7 , wherein the antisense oligonucleotide is chemically linked to one or more moieties or conjugates that enhance the activity, cellular distribution or cellular uptake of the oligonucleotide

Metadata:
- Claim Count in Document: 29.0
- Percentile: 99.0
- Lexical Diversity: 1.10345
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14944886', '14740097', '15661750', '14108137', '13509331']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8232285140882987
- 35 USC 102 Novelty (BERT): 0.7819804096133725
- Combined Prediction Score: 0.819103703640806
- Mean Citation Score: 969.5078
- Max Citation Score: 1027.9857
- Similarity Product: 931.181170840502

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test